Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from RBC

Small‑Cap Stocks Got a Payrolls Boost — But CPI Is the Real Test

A surprise contraction in US payrolls has given the stock market a break from worrying about a near-term interest-rate increase. Whether it gives small-cap stocks a durable reprieve depends on Wednesday’s inflation report.

Benzinga

Wall Street Can't Agree on Palantir. Here's What Investors Should Do Next

Palantir's blockbuster Q2 results has Wall Street divided with valuation fears and growth bulls tussling.

Barchart

Analysts Are Slashing Price Targets on AppLovin Stock. Here's Why.

AppLovin stock sinks as analysts lower price targets following Q2 earnings. Here’s how you should play APP shares at current levels.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

What Tesla Stands to Lose If It Walks Away From China

Reports Tesla may sell or close its China unit raise analyst concerns, as RBC estimates the market holds 25% of Tesla's value, mostly tied to future Optimus and robotaxi bets.

MarketBeat

Democratic National Committee announces proposed early states for 2028 Democratic presidential calendar

Welcome to the Tuesday, Aug. 4, 2026, Brew.

Ballotpedia

Democratic National Committee announces proposed early states for 2028 Democratic presidential calendar

The Democratic National Committee (DNC) announced on July 24, 2026, that its Rules and Bylaws Committee (RBC) had voted to select the first six states for the 2028 Democratic presidential nominating calendar. Those states and their proposed primary dates are as follows:

Ballotpedia

Retrofit rewards to usher in new era of fire-safe homes

The promise of lower insurance premiums in return for ember screens and other bushfire-safe upgrades has more households retrofitting for the future climate.

AAP

Read news from The Economist, FT, and more,
with one subscription

RBC Capital Just Downgraded AVAV Stock. Here's Why.

RBC analysts downgrade AeroVironment stock to "Sector Perform." Here’s why the firm recommends caution in playing AVAV shares at current levels.

Barchart

How 'Inner Wealth' Is Reshaping Financial Planning for High-Net-Worth Women

High-net-worth women are redefining financial freedom and aligning wealth with values — without sacrificing returns. Financial plans must evolve with them.

Kiplinger

Bud Cauley Claims Emotional RBC Canadian Open Victory

The American fired a five-under final round 65 to claim victory at TPC Toronto, wrapping up his first win on the PGA Tour in 239 starts

Golf Monthly

Being your own boss doesn’t always pay off: What 30 years of data reveal

More than 2.6 million Canadians work for themselves, and according to an annual RBC poll conducted in 2025, 59 per cent of Canadians aspire to own a business — the highest level since 2017.

The Conversation

Major Russian mobile provider Beeline launches 'whitelist VPN' for Netflix and Spotify

Russian telecom giant Beeline has introduced a built-in "whitelist VPN," granting users direct access to Western streaming and gaming platforms that suspended their operations in the country.

TechRadar

Ukraine war briefing: Ending war before winter ‘correct and realistic’, says senior Kyiv aide

Budanov backs Zelenskyy call to capitalise on Kyiv’s strong position on battlefield; Kyiv under heavy attack into Tuesday morning. What we know on day 1,560

The Guardian - AU

RBC Just Upped Its Price Target on Marvell Technology Stock. Here's Why

Marvell stock gains as robust Q1 earnings makes RBC raise its price target to $240. Here’s why the investment firm is bullish on MRVL shares.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Royal Bank Of Canada Q2 Earnings Call Highlights

Royal Bank Of Canada (NYSE:RY) reported fiscal second-quarter earnings of CAD 5.5 billion, with adjusted earnings of CAD 5.6 billion, as management highlighted strong results across capital markets, wealth management and Canadian banking businesses. President and Chief Executive Officer Dave McKay

MarketBeat

Mirum Pharmaceuticals Enters Catalyst-Rich Stretch as LIVMARLI Sales and Pipeline Advance

Mirum Pharmaceuticals (NASDAQ:MIRM) executives said the rare disease company is entering a catalyst-heavy period, with recent positive clinical updates, ongoing commercial momentum for LIVMARLI and additional business development activity expanding its portfolio. Speaking at RBC Capital Markets’ 20

Barchart

Walmart Is Supposed to Be a Safe-Haven Stock. High Gas Prices Are Hitting Its Shares Instead.

While once treated like a defensive fortress by investors, high fuel costs are squeezing shoppers, hurting margins, and shaking confidence in Walmart now.

MarketBeat

Opus Genetics Touts Retinal Gene Therapy Pipeline, September BEST1 Data Catalyst

Opus Genetics (NASDAQ:IRD) is advancing a portfolio of gene therapies for inherited retinal diseases, with two programs already in the clinic and three more expected to enter clinical testing within the next 12 months, President Dr. Ben Yerxa said during a fireside chat at RBC Capital Markets’ 2026

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Ionis Pharmaceuticals Eyes Big Year With TRYNGOLZA Decision, 5 Phase 3 Readouts

Ionis Pharmaceuticals (NASDAQ:IONS) highlighted a busy slate of regulatory decisions, clinical readouts and partnered programs during a presentation at RBC Capital Markets’ Global Healthcare Conference, with Chief Development Officer Holly Kordasiewicz saying the company is moving from recent launch

Barchart

Dear F5 Stock Fans, Mark Your Calendars for May 28

Upcoming analyst day is likely to provide further insights on AI-driven growth momentum.

MarketBeat

CG Oncology Touts Bladder Cancer Data, Q4 Filing Plans at RBC Conference

CG Oncology (NASDAQ:CGON) executives used an RBC Capital Markets fireside chat to outline recent clinical data for cretostimogene, the company’s investigational therapy for non-muscle invasive bladder cancer, and to discuss upcoming regulatory, manufacturing and commercial milestones. The discussio

MarketBeat

Addus HomeCare Says License Moratorium Won’t Slow Personal Care Growth, M&A

Addus HomeCare (NASDAQ:ADUS) executives said a new federal moratorium on certain home health licenses should have little effect on the company’s growth plans, while highlighting continued improvement in personal care services trends and ongoing acquisition opportunities. Speaking at an RBC healthca

Barchart

Regeneron Sinks 10% on Failed Phase 3 Melanoma Trial. What Comes Next for REGN Stock.

Regeneron stock sinks as fianlimab Phase 3 trial fails to meet primary endpoint. But RBC continues to see significant upside in REGN shares from here.

MarketBeat

H&R Real Estate Investment Trust Q1 Earnings Call Highlights

H&R Real Estate Investment Trust (TSE:HR.UN) said its U.S. multifamily operations are showing early signs of improvement following the transition of property management to Greystar, while management continues to work through asset sales and the final stages of its multiyear strategic repositioni

MarketBeat

Canadian Tire Q1 Earnings Call Highlights

Canadian Tire (TSE:CTC) reported first-quarter 2026 earnings that management said came in ahead of plan, as stronger retail revenue and disciplined expense management helped offset weather-related weakness in comparable sales. President and CEO Greg Hicks said the company “continued to perform and

1 2 3 4 5

People

Sudarshan Yellamaraju

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.